Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
In this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella mul...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5544235?pdf=render |
id |
doaj-5e2cd291b0fc49ee95f216e01d352d75 |
---|---|
record_format |
Article |
spelling |
doaj-5e2cd291b0fc49ee95f216e01d352d752020-11-25T02:29:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018286310.1371/journal.pone.0182863Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.Maleck V VasseurMarlene Z LacroixPierre-Louis ToutainAlain Bousquet-MelouAude A FerranIn this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella multocida was administered as pathogenic agent to immunocompetent mice, 60% of the animals exhibited clinical symptoms of pneumonia 2 to 4 days after bacterial contamination of the lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and cefquinome, a fourth generation cephalosporin developed for food animals. First, a pharmacokinetic study was performed in infected mice to determine the exposure to amoxicillin or cefquinome required to treat clinically affected animals, based on the targeted values of PK/PD indices for beta-lactams. We then confirmed that these doses resulted in a 100% clinical cure rate in animals exhibiting clinical signs of infection and harboring a high pathogenic inoculum. More interestingly, we also showed that the same 100% clinical cure could be obtained in our model with 10-fold lower doses in animals at pre-patent stages of infection i.e. when harboring a low pathogenic inoculum. At the group level, antimicrobial drug consumption was reduced by treating animals at an early stage of the infection course with a pre-patent tailored dose. These results suggest that early treatment with a dose suitably adjusted to the stage of infection might help to reduce both overall antibiotic consumption and resistance selection pressure in the animals and in the environment.http://europepmc.org/articles/PMC5544235?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maleck V Vasseur Marlene Z Lacroix Pierre-Louis Toutain Alain Bousquet-Melou Aude A Ferran |
spellingShingle |
Maleck V Vasseur Marlene Z Lacroix Pierre-Louis Toutain Alain Bousquet-Melou Aude A Ferran Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. PLoS ONE |
author_facet |
Maleck V Vasseur Marlene Z Lacroix Pierre-Louis Toutain Alain Bousquet-Melou Aude A Ferran |
author_sort |
Maleck V Vasseur |
title |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. |
title_short |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. |
title_full |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. |
title_fullStr |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. |
title_full_unstemmed |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice. |
title_sort |
infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: a pasteurella multocida experimental pneumonia in mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
In this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella multocida was administered as pathogenic agent to immunocompetent mice, 60% of the animals exhibited clinical symptoms of pneumonia 2 to 4 days after bacterial contamination of the lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and cefquinome, a fourth generation cephalosporin developed for food animals. First, a pharmacokinetic study was performed in infected mice to determine the exposure to amoxicillin or cefquinome required to treat clinically affected animals, based on the targeted values of PK/PD indices for beta-lactams. We then confirmed that these doses resulted in a 100% clinical cure rate in animals exhibiting clinical signs of infection and harboring a high pathogenic inoculum. More interestingly, we also showed that the same 100% clinical cure could be obtained in our model with 10-fold lower doses in animals at pre-patent stages of infection i.e. when harboring a low pathogenic inoculum. At the group level, antimicrobial drug consumption was reduced by treating animals at an early stage of the infection course with a pre-patent tailored dose. These results suggest that early treatment with a dose suitably adjusted to the stage of infection might help to reduce both overall antibiotic consumption and resistance selection pressure in the animals and in the environment. |
url |
http://europepmc.org/articles/PMC5544235?pdf=render |
work_keys_str_mv |
AT maleckvvasseur infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice AT marlenezlacroix infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice AT pierrelouistoutain infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice AT alainbousquetmelou infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice AT audeaferran infectionstageadjusteddoseofbetalactamsforparsimoniousandefficientantibiotictreatmentsapasteurellamultocidaexperimentalpneumoniainmice |
_version_ |
1724834434476146688 |